MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. Massive losses of -62.07% were the result for the BUY prediction by Stakeholder. Stakeholder has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG ADR | - | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % | 48,88 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % | 83,74 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % | 60,39 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % | 61,27 % |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA